| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/05/2011 | CA2288994C Polyalkylene oxide-modified single chain polypeptides |
| 07/05/2011 | CA2288540C Defined serumfree medical solution for ophthalmology |
| 07/05/2011 | CA2220133C Recombinant vesiculoviruses and their uses |
| 07/05/2011 | CA2204636C Diagnostic method and kit for determining kell blood group genotype |
| 06/30/2011 | WO2011079307A2 Methods and compositions for treating neurological disorders |
| 06/30/2011 | WO2011079277A2 Genetic markers associated with drought tolerance in maize |
| 06/30/2011 | WO2011079070A1 Furin-knockdown bi-functional rna |
| 06/30/2011 | WO2011079018A2 Differentiation of human embryonic stem cells |
| 06/30/2011 | WO2011079017A2 Differentiation of human embryonic stem cells |
| 06/30/2011 | WO2011079004A1 Cell line 3m |
| 06/30/2011 | WO2011078799A1 Treatment of bone fracture |
| 06/30/2011 | WO2011078784A1 Device and method for biological sample purification and enrichment |
| 06/30/2011 | WO2011078778A1 Method for assessing the sensitisation capability of a compound |
| 06/30/2011 | WO2011078351A1 Secretion signal sequence, and protein expression system utilizing same |
| 06/30/2011 | WO2011078338A1 Protein having novel terpene synthase activity and gene encoding same |
| 06/30/2011 | WO2011078332A1 Polypeptide modification method for purifying polypeptide multimers |
| 06/30/2011 | WO2011078308A1 GENE Dro1 CONTROLLING DEEP-ROOTED CHARACTERISTICS OF PLANT AND UTILIZATION OF SAME |
| 06/30/2011 | WO2011078301A1 Method for searching and screening for target of anti-cancer agent using non-human animal model having nog established cancer cell line transplanted therein |
| 06/30/2011 | WO2011078011A1 Method for culturing dental pulp cells and method for transporting extracted tooth for preservation |
| 06/30/2011 | WO2011077931A1 Method for producing fatty acid-containing lipid using thioesterase variant |
| 06/30/2011 | WO2011077894A1 Method for enhancing formation of spheroid and culture medium for enhancing formation of spheroid |
| 06/30/2011 | WO2011077086A2 Agents having tissue generative activity |
| 06/30/2011 | WO2011077035A1 Method for culturing adherent cells |
| 06/30/2011 | WO2011076870A1 Promoter sequences |
| 06/30/2011 | WO2011076447A1 Apparatus and method for cell exploitation |
| 06/30/2011 | WO2011076414A1 Expansion medium for cd34-negative stem cells |
| 06/30/2011 | WO2011031676A3 Depleting immunosuppressive monocytes within a mammal |
| 06/30/2011 | WO2011025179A3 Method of inducing the differentiation of human embryonic stem cells into mesenchymal stem cells |
| 06/30/2011 | WO2010064054A8 Cellular compositions for use in therapy |
| 06/30/2011 | US20110162114 Selection method ii |
| 06/30/2011 | US20110162113 Antibodies |
| 06/30/2011 | US20110162109 Plants Having Modified Growth Characteristics and a Method for Making the Same |
| 06/30/2011 | US20110162107 Plants having improved growth characteristics and methods for making the same |
| 06/30/2011 | US20110162105 Nucleic Acids Encoding Desaturases and Modified Plant Oil |
| 06/30/2011 | US20110162104 Plant Membrane Bound O-Acyl Transferase (MBOAT) Family Protein Sequences And Their Uses For Altering Fatty Acid Compositions |
| 06/30/2011 | US20110162101 Plant Transcription Factors |
| 06/30/2011 | US20110162099 Lettuce named brp9321 |
| 06/30/2011 | US20110162098 Elite event ee-gm3 and methods and kits for identifying such event in biological samples |
| 06/30/2011 | US20110162096 Gene Therapy Using Transposon-Based Vectors |
| 06/30/2011 | US20110162095 TNFSF Single Chain Molecules |
| 06/30/2011 | US20110162094 Modified human factor vii/viia and pharmaceutical composition containing the same |
| 06/30/2011 | US20110162093 Methods for producing antibodies |
| 06/30/2011 | US20110160869 Biocompatible materials for mammalian stem cell growth and differentiation |
| 06/30/2011 | US20110160857 Methods for collecting and processing autografts, processed autografts, kits for collecting and transporting autografts, and tools for preparing autografts |
| 06/30/2011 | US20110160445 Heparin-Binding Growth Factor (HBGF) Polypeptides |
| 06/30/2011 | US20110160291 Oligonucleotide Compositions and Their Use to Induce Apoptosis |
| 06/30/2011 | US20110160286 Allele-specific rna interference |
| 06/30/2011 | US20110160284 Supercoiled minicircle dna for gene therapy applications |
| 06/30/2011 | US20110160280 Cancer-related genes, cdca5, epha7, stk31 and wdhd1 |
| 06/30/2011 | US20110160278 Methods For Selectively Modulating Survivin Apoptosis Pathways |
| 06/30/2011 | US20110160263 Small molecule inhibition of PDZ-domain interaction |
| 06/30/2011 | US20110160240 Polymorphs and salts of a kinase inhibitor |
| 06/30/2011 | US20110160236 Treating Vascular Events with Statins by Inhibiting PAR-1 and PAR-4 |
| 06/30/2011 | US20110160235 Triazolyl tropane derivatives |
| 06/30/2011 | US20110160187 3-aryl-5,6-disubstituted pyridazines |
| 06/30/2011 | US20110160170 Compositions and methods of inducing endoplasmic reticulum stress response |
| 06/30/2011 | US20110160146 Conjungation of Small Molecules to Octaarginine Transporters for Overcoming Multi-Drug Resistance |
| 06/30/2011 | US20110160126 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
| 06/30/2011 | US20110160120 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| 06/30/2011 | US20110160119 Anti-inflammatory compounds and uses thereof |
| 06/30/2011 | US20110159607 Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof |
| 06/30/2011 | US20110159592 COMPOSITION FOR REPROGRAMMING SOMATIC CELLS TO GENERATE INDUCED PLURIPOTENT STEM CELLS, COMPRISING Oct4 IN COMBINATION WITH Bmi1 OR ITS UPSTREAM REGULATOR, AND METHOD FOR GENERATING INDUCED PLURIPOTENT STEM CELLS USING THE SAME |
| 06/30/2011 | US20110159590 Cell/tissue culturing device, system and method |
| 06/30/2011 | US20110159589 Methods of inhibiting inflammation with antagonists to il-17a, il-17f, and il-23p19 |
| 06/30/2011 | US20110159588 Methods for Modulating a PDGF-AA Mediated Biological Response |
| 06/30/2011 | US20110159587 Chimeric Molecules to Modulate Gene Expression |
| 06/30/2011 | US20110159586 Compositions and methods for modulating gene expression using asymmetrically-active precursor polynucleotides |
| 06/30/2011 | US20110159585 Directly injectable formulations which provide enhanced cryoprotection of cell products |
| 06/30/2011 | US20110159584 Method of loading and distributing cells in a bioreactor of a cell expansion system |
| 06/30/2011 | US20110159562 Apparatus and methods for controlling cellular development |
| 06/30/2011 | US20110159542 Immunosuppressive polypeptides and nucleic acids |
| 06/30/2011 | US20110159541 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT8) gene expression |
| 06/30/2011 | US20110159540 Methods for Chemically Synthesizing Immunoglobulin Chimeric Proteins |
| 06/30/2011 | US20110159535 Preparation and use of nucleated red blood cell simulating particles and hematology control mixtures |
| 06/30/2011 | US20110159532 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 06/30/2011 | US20110159529 Fusion protein having luminescence activity |
| 06/30/2011 | US20110159525 Methods to determine immunogenicity of humanized anti-tag 72 cc49 antibodies |
| 06/30/2011 | US20110159514 Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof |
| 06/30/2011 | US20110159486 Cell cycle switch 52(ccs52) and methods for increasing yield |
| 06/30/2011 | US20110159121 Methods and compositions for identifying, producing and using plant-derived products for modulating cell function and aging |
| 06/30/2011 | US20110159112 Recombinant alpha-fetoprotein and compositions thereof |
| 06/30/2011 | US20110159098 Stabilization and delivery of nucleic acid complexes |
| 06/30/2011 | US20110159071 Isolation and Identification of Glycosaminoglycans |
| 06/30/2011 | US20110159070 Biomaterials and implants for enhanced cartilage formation, and methods for making and using them |
| 06/30/2011 | US20110159056 Methods and materials for stimulating proliferation of stem cells |
| 06/30/2011 | US20110159053 Preparation of a cell concentrate from a physiological solution |
| 06/30/2011 | US20110159041 Chlamydia Trachomatis Genomic Sequence and Polypeptides, Fragments Thereof and Uses Thereof, in Particular for the Diagnosis, Prevention and Treatment of Infection |
| 06/30/2011 | US20110159021 Xbp1, cd138, and cs1 peptides |
| 06/30/2011 | US20110159018 Complement factor h-derived short consensus repeat-antibody constructs |
| 06/30/2011 | US20110159017 Trytophan catabolism in cancer treatment and diagnosis |
| 06/30/2011 | US20110159015 Human antibodies to human angiopoietin-like protein 4 |
| 06/30/2011 | US20110159013 Anti-ADDL Antibodies and Uses Thereof |
| 06/30/2011 | US20110159012 Method for isolating neural cells using tenascin-r compounds |
| 06/30/2011 | US20110159009 Anti-vegf antibodies |
| 06/30/2011 | US20110159007 Stable and soluble antibodies inhibiting tnf alpha |
| 06/30/2011 | US20110159003 Ligands That Bind Il-4 and/or Il-13 |
| 06/30/2011 | US20110158999 Antagonists of protease activated receptor-1 (par1) |
| 06/30/2011 | US20110158997 Single chain fragment variable antibody libraries and uses thereof |
| 06/30/2011 | US20110158995 Multi-Specific Binding Proteins Targeting B Cell Disorders |
| 06/30/2011 | US20110158994 Polypeptides specifically binding to vascular endothelial growth factor receptor-2 and methods therefor |